HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kun-Tu Yeh Selected Research

Casein Kinase 1 epsilon

1/2019Impact of Polymorphisms in Casein Kinase 1 Epsilon and Environmental Factors in Oral Cancer Susceptibility.
3/2016Low cytoplasmic casein kinase 1 epsilon expression predicts poor prognosis in patients with hepatocellular carcinoma.
2/2014Casein kinase 1 epsilon expression predicts poorer prognosis in low T-stage oral cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kun-Tu Yeh Research Topics

Disease

98Neoplasms (Cancer)
10/2022 - 01/2002
30Carcinogenesis
05/2022 - 06/2003
24Hepatocellular Carcinoma (Hepatoma)
09/2020 - 01/2002
23Mouth Neoplasms (Oral Cancer)
06/2021 - 05/2003
18Squamous Cell Carcinoma of Head and Neck
04/2021 - 11/2002
14Neoplasm Metastasis (Metastasis)
09/2020 - 11/2002
13Lung Neoplasms (Lung Cancer)
09/2020 - 05/2003
10Colorectal Neoplasms (Colorectal Cancer)
03/2017 - 05/2004
10Breast Neoplasms (Breast Cancer)
12/2014 - 11/2002
9Carcinoma (Carcinomatosis)
01/2013 - 06/2003
8Lymphatic Metastasis
01/2018 - 05/2004
7Fibrosis (Cirrhosis)
06/2021 - 02/2009
6Melanoma (Melanoma, Malignant)
02/2022 - 05/2009
5Stomach Neoplasms (Stomach Cancer)
01/2021 - 02/2009
5Infections
01/2020 - 09/2003
5Endometrial Neoplasms (Endometrial Cancer)
05/2017 - 12/2005
4Inflammation (Inflammations)
04/2021 - 11/2015
4Adenocarcinoma of Lung
09/2020 - 11/2010
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2020 - 11/2008
4Colonic Neoplasms (Colon Cancer)
12/2017 - 05/2004
4Adenocarcinoma
10/2014 - 01/2004
3Hyperplasia
01/2019 - 01/2010
3Thyroid Neoplasms (Thyroid Cancer)
12/2018 - 05/2003
3Chronic Renal Insufficiency
11/2016 - 01/2011
3Pterygium
01/2012 - 06/2009
3Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2003 - 05/2003
2Gout
11/2016 - 11/2015
2Type 2 Diabetes Mellitus (MODY)
11/2016 - 11/2015
2Adenoma (Adenomas)
10/2014 - 01/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2011 - 04/2006

Drug/Important Bio-Agent (IBA)

39Proteins (Proteins, Gene)FDA Link
09/2020 - 01/2002
19DNA (Deoxyribonucleic Acid)IBA
10/2022 - 02/2003
13Messenger RNA (mRNA)IBA
01/2019 - 09/2003
11Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2009
9Small Interfering RNA (siRNA)IBA
01/2020 - 07/2010
5Oncogene Proteins (Oncogene Protein)IBA
01/2019 - 11/2007
5Protein Kinases (Protein Kinase)IBA
11/2016 - 01/2009
5Phosphotransferases (Kinase)IBA
11/2016 - 05/2010
5Cellular Apoptosis Susceptibility ProteinIBA
01/2015 - 05/2009
5ErbB Receptors (EGF Receptor)IBA
09/2014 - 05/2010
5Histones (Histone)IBA
01/2014 - 01/2002
5Mitochondrial DNA (mtDNA)IBA
01/2011 - 06/2003
4Arecoline (Arecolin)IBA
04/2021 - 01/2010
4Monoclonal AntibodiesIBA
08/2016 - 07/2003
4ParaffinIBA
09/2014 - 06/2007
4MethyltransferasesIBA
06/2013 - 11/2008
4PlectinIBA
09/2008 - 01/2004
3AntioxidantsIBA
04/2021 - 03/2019
3arecoline 1-oxideIBA
04/2021 - 06/2015
3Indicators and Reagents (Reagents)IBA
09/2020 - 11/2017
3NickelIBA
01/2020 - 11/2017
3Casein Kinase 1 epsilonIBA
01/2019 - 02/2014
3Epidermal Growth Factor (EGF)IBA
01/2018 - 06/2007
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2016 - 09/2006
3Transcription Factors (Transcription Factor)IBA
09/2015 - 02/2009
3Formaldehyde (Formol)FDA Link
09/2014 - 06/2007
3Matrix Metalloproteinases (MMPs)IBA
12/2012 - 03/2010
3Membrane Proteins (Integral Membrane Proteins)IBA
12/2012 - 09/2003
3Codon (Codons)IBA
09/2010 - 06/2009
3Keratins (Keratin)IBA
01/2008 - 01/2002
3Caveolin 1IBA
10/2004 - 09/2003
2Factor X (Stuart Factor)IBA
05/2022 - 12/2014
2Mitogen-Activated Protein Kinase 3IBA
02/2022 - 01/2015
2EnzymesIBA
04/2021 - 01/2012
2hydrogen sulfite (bisulfite)IBA
01/2021 - 02/2011
2Peptide Hydrolases (Proteases)FDA Link
02/2020 - 12/2012
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 12/2017
2CytokinesIBA
01/2020 - 01/2010
2Metformin (Glucophage)FDA LinkGeneric
01/2020 - 12/2017
2Environmental CarcinogensIBA
01/2019 - 12/2017
2Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2019 - 02/2018
2CollagenIBA
01/2019 - 06/2015
2MicroRNAs (MicroRNA)IBA
12/2018 - 11/2017
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018 - 01/2010
2CarcinogensIBA
11/2017 - 01/2013
2Carcinoembryonic AntigenIBA
03/2017 - 04/2010
2RNA (Ribonucleic Acid)IBA
03/2017 - 04/2013
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2017 - 04/2011
2Mitogen-Activated Protein KinasesIBA
01/2016 - 01/2012
2caffeic acid phenethyl esterIBA
01/2016 - 01/2012
2Globo-HIBA
12/2014 - 03/2014
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2013 - 12/2012
2Interleukin-10 (Interleukin 10)IBA
01/2013 - 01/2012
2CreatinineIBA
01/2013 - 01/2011
2NucleotidesIBA
01/2013 - 06/2003
2Nuclear Proteins (Protein, Nuclear)IBA
09/2012 - 02/2012
2Carbonic Anhydrases (Carbonic Anhydrase)IBA
08/2012 - 09/2003
2Telomerase (Telomerase Reverse Transcriptase)IBA
10/2011 - 11/2010
2Cadherins (E-Cadherin)IBA
09/2011 - 11/2002
2Estrogen ReceptorsIBA
02/2011 - 10/2004
2Protein Kinase CIBA
09/2010 - 09/2005
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
09/2010 - 01/2009
2Coloring Agents (Dyes)IBA
10/2004 - 11/2002
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
04/2004 - 06/2003
2Poly CIBA
04/2004 - 06/2003
2desmuslin (synemin)IBA
01/2004 - 01/2004
2beta CateninIBA
10/2003 - 09/2003

Therapy/Procedure

11Therapeutics
01/2019 - 11/2010
2Chemoprevention
01/2020 - 12/2017
2Chronotherapy
12/2005 - 07/2005